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A  large and heterogeneous group of esterases are inhibited  by organophos- 
phorus inhibitors  such  as  diisopropyl fluorophosphate  (DFP),  and  the  phos- 
phonate esters (1-3).  For some of these enzymes there is direct evidence, and 
for others good presumptive evidence,  that the inhibition is due  to the phos- 
phorylafion of the hydroxyl group of a  serine present in the active center  1 of 
the enzyme. This phosphorylation is deemed to be essentially the same as the 
process  by which  the  substrate  of these  enzymes acylates  the  active  center 
(4,  5).  The  difference  between  substrate  and  inhibitor  is  that  the  acylated 
enzyme is very rapidly deacylated,  restoring  its  activity,  whereas  the  phos- 
phorylated enzyme is dephosphorylated very slowly or not at all. To stress the 
substrate-like activity of organophosphorus inhibitors, they have been termed 
"hemisubstrates" (6). In accord with the substrate nature  of these inhibitors, 
distinct differences in reactivity with different enzymes are observed (7). This 
allows these enzymes to be characterized, not only in the usual manner by their 
reactivity with complete substrates, but also by the pattern of their reactivity 
with hemisubstrates such as phosphonate esters. 
The first component of guinea pig complement is an esterase (8, 9)  inhibited by 
organophosphorus compounds such as DFP (10, 11) and phosphonate esters (3). The 
antigen-induced release of histamine from peffused, sliced guinea pig lung is also in- 
hibited by DFP suggesting  that an esterase is involved (12). The additional finding 
that aromatic amino acid esters were potent inhibitors of the antigen-induced hista- 
mine release led to the hypothesis that the DFP-inhibited esterase has a chymotrypsin- 
like substrate specificity  (12). It was realized however that there is no rigorous, direct 
* This investigation was supported in part by United States Public Health Service Grant 
A1-04536 to Dr. Austen. 
1 "Active center" is used here in the same sense as by Vallee as referring "... to all those 
features of primary, secondary and tertiary  structures.., which are required for substrate 
binding, specificity or hydrolysis of the substrate  (29)." 
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evidence bearing on  this point  (reference  13,  p.  44).  The  striking similarities and 
several differences between the hemolytic action of complement, and in vitro antigen- 
induced release of histamine summarized previously (12)  have not provided a  basis 
for a definite conclusion as to the role of complement in this latter reaction. 
In this study, a  number of p-nitrophenylethyl phosphonates of the structure 
O  Rpl(oc,as)o  o, 
where  R  is  phenyl  alkyl,  alkyl, co-chloroalkyl, and  o~-aminoalkyl have  been 
tested for their ability to inhibit the activated first component (C'la) of guinea 
pig  complement,  and  the  antigen-induced  release  of  histamine  from  sliced 
guinea  pig  lung.  In  this  manner,  the  antigen-antibody-activated esterases, 
respectively  involved  in  the  two  reactions  were  further  characterized  and 
simultaneously compared. 
Materials and Methods 
Phosphonate Inhibitors.--The  p-nitrophenylethyl  alkyl, phenyl alkyl, and the ¢o-chloroalkyl 
phosphonates  have been described  previously (7,  14,  15). The synthesis and properties of 
p-nitrophenylethy160-aminoalkyl  phosphonates will be described subsequently by Mr. Robert 
Stat~,  Mr. Dennis Werber, and Mr.  Gim Tijoe of American  University. These esters are 
unstable. They break down to yield the inactive phosphonic acid and free p-rtitrophenol. In all 
cases, the concentration of phosphonate ester was measured  in terms of the actual bound 
p-nitrophenol as assayed on the day of experimentation. 
Buffers.--Three  buffers were used in the study of the inhibition of C'la: triethanolamine- 
buffered saline (TBS) with added magnesium, calcium, and gelatin (16); "low ionic strength 
(0.065/~) buffer,"  pH 7.4 with maunitol, as described in reference 17 except that triethanol- 
amine was substituted for veronal; and "low ionic strength (0.065/z) buffer,"  pH 8.0. 
The reaction of inhibitor with EAC'la, 4 was performed in the buffer of low ionic strength, 
pH 8.0. The low ionic strength prevented dissociation of C'la from the cell during the reaction 
(17), and pH 8.0 was used in order for the results to be directly comparable with previous work 
on other enzymes (7, 15). 
Tyrode's buffer was employed for the study of histamine release. 
Guinea Pig Serum.--Fresh  frozen  guinea  pig serum  absorbed three  times with  sheep 
erythrocytes at 0°C  (reference  18, p.  151) was  the source  of the complement  used in the 
preparation of EAC'I, 4, 2 and other cell intermediates. Commercial fresh frozen or lyophil- 
ized complement  reconstituted with the diluent provided was employed in the study of the 
inhibition of whole complement action by phosphonates. 
Red Cells.--Sheep red cells were collected in sterile Alsever's and just before use, washed, 
and suspended in TBS buffer at a concentration of 2.0 X  109/ml. They were sensitized with 
an  equal volume  of five  times the optimal concentration of commercial  hemolysin.  The 
preparation of C'2, EAC'4, EAC'I, 4, and CrEDTA has been described previously (reference 
18, p. 133). EAC'la, 4, 2 were prepared as described  (reference 18, p. 133) except that the 
EA were cooled to exactly 0°C prior to adding 2.0 ml of fresh guinea pig serum per 100 mi of 
EA; the guinea pig serum and EA were left in contact at 0°C for 10 minutes before centrifuga- 
tion and washing. 
Inhibition of C'la.--Ten ml of EAC'la, 4 (1.33 X  10S/ml, 50 to 100 effective sites per cell) 493 
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in low ioni  c strength buffer, pH 8.0, was added to 10 ml of a  I: I00 dilution of a stock solution 
of phosphonate in acetone. Ten m] of a  1:50 dilution of the stock inhibitor in 50 per cent 
acetone was used in the case of the aminoalkyls. All solutions were brought to 25.0°C  before 
mixing, and were maintained at 25.0°C  in a water bath during the reaction. One ml aliquots 
were removed at 3 minutes and I0 minutes after mixing, and after that at 10-minute intervals 
for 60 minutes. The samples were immediately added to 5 ml of ice-cold, low ionic strength 
buffer, pH 7.4, and the cells immediately centrifuged, washed in the latter buffer, resuspended 
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FIo. 1.  The  progressive,  irreversible  inhibition  of  C'la  by  p-nitrophenylethyl phenyl 
phosphonate. 
in 1 ml TBS and stored at I°C until the sampling was complete. At this time, a  1:75 dilution 
of ceils was prepared from the contents of each tube. Five-tenths ml of this was added to 0.5 
ml of EAC'4 and assayed for the number of effective EAC'Ia, 4 sites remaining, essentially 
as described in reference 19. If necessary the number of effective sites remaining was corrected 
for any non-specific loss exhibited in the control. 
In the case where inhibitory activity was low because the compounds were too insoluble to 
be run at a  sufficiently high concentration the sampling was done at 20-minute intervals for 
2 hours. 
A control tube containing 10 ml of EAC'la, 4, to which 10 ml of 1 per cent acetone in low 
ionic strength buffer, pH 8.0, was added, was sampled at zero time, 30 minutes, and 1 hour. 494  SPECIFICITY  OF  INHIBITION  BY  PttOSPHONATE  ESTERS 
If the 2 hour time was employed the control tubes were sampled also at 90 and 120 minutes. 
The reaction between organophosphorus inhibitors and susceptible enzymes is a  progres- 
sive, bimolecular one; with sufficient excess of inhibitor over enzyme the rate is first order, 
independent of the enzyme concentration, and directly proportional to inhibitor concentration 
(reference 1, p.  120). This also holds for the reaction of phosphonate esters with C'la, as is 
demonstrated in Fig. 1. From the slope of the straight line obtained by plotting the logarithm 
of the effective sites (s) remaining against the time (0 at a given inhibitor concentration (I), 
the bimolecular rate constant (k) was calculated by means of Equation 1: 
--kI 
logt0s = 2.303t  (1) 
For ease of comparison with previous work, and also for convenience of presentation, the so 
called Is0, the molar concentration of inhibitor giving 50 per cent inhibition when inhibitor 
and cells were allowed to stand 15 minutes at 25°C was calculated by means of Equation 2: 
0.0453  I~0 =--y-  (2) 
From the I~0, the negative logarithm of the I50, termed pI~o was obtained. 
Inhibition  of Whole Complement by Phosphonate Inhibitor.--The inhibition of whole guinea 
pig hemolytic complement by phosphonate inhibitors at 37°C  was studied as described in 
reference 3. The activity remaining was expressed in terms of the ratio of the volume of a 
given dilution of complement without inhibitor giving 50 per cent hemolysis to the volume of 
the same dilution of complement with inhibitor also giving 50 per cent hemolysis (3). 
Histamine Rdease.--Gtfinea  pigs were sensitized with 10 per cent egg albumin as described 
(12)  except that one to two intraperitoneal booster injections of 1 mg egg albumin in alum 
were given 2 to 6 weeks prior to the day of experimentation. Peffused, sliced, washed, lung 
tissue was prepared and divided into replicate samples as described (12). The replicate samples 
were washed twice and suspended in 3.0 ml warm Tyrode's solution with or without inhibitor. 
The solution of inhibitor was prepared by adding 0.1 ml of stock inhibitor in acetone to 59.9 
ml of Tyrode's solution; control solution without inhibitor contained the same concentration 
of acetone (0.17 per cent). This concentration of acetone was found not to interfere with his- 
tamine release by antigen. Ten seconds after the addition of inhibitor to tissue 1.0 mg of egg 
albumin per ml of reaction mixture was added. After 15 minutes at 37°C the supemate was 
removed and assayed for histamine (12). 
The comparison of the activity of a  given series of phosphonate inhibitors, or of one in- 
hibitor with another, was made within the same experiment using triplicate tissue samples for 
each concentration of each inhibitor. 
Enzymes exist in blood and tissues which are capable of hydrolyzing and thus inactivating 
organophosphorus esters (20). In order to be certain that hydrolysis by the lung tissue was 
not responsible for any differences in inhibitory activity, the ability of perfused, sliced lung 
tissue to hydrolyze each of the phosphonate esters used was tested by measuring the increase 
of free p-nitrophenol after a  15 minute reaction period at 37°C.  None of the phosphonates de- 
scribed here were hydrolyzed to an extent greater than 2 per cent of the initial concentration 
of phosphonate ester, showing that the differences observed could not be due to an accelerated 
breakdown of a particular phosphonate. 
RESULTS 
Inhibition  of Complement A ctivity.-- 
Inhibition  of CPla: Fig. 2 illustrates the effect of structural alterations within 
the series of phenyl alkyl (Fig. 2, A), alkyl (Fig. 2, B), and ¢0-chloroalkyl phos- ELMER  L.  BECKER  AND  K.  I~RANK  AUSTEN  495 
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FIG. 2.  The relationship between the structure of the p-nitrophenylethyl phenyl alkyl  (A), alkyl  (B), 
and oJ-chloroalkyl-phosphonates, (C),  and  the inhibition of acetylcholinesterase, ........  ; chymotrypsin, 
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phonates (Fig.  2, C) on the inhibition of C'la. For comparison,  the inhibitory 
activity of these same compounds against "true" acetylcholinesterase, trypsin, 
and  chymotrypsin reported previously (7,  15) is  also plotted. The inhibition 
pattern  for acetylcholinesterase differs  completely from any  of the other en- 
zymes. 
In the phenyl alkyl series,  C'la shows  a  distinct peak in susceptibility to 
inhibition with the benzyl, and a minimum with the phenyl ethyl phosphonate. 
Trypsin shows one maximum at the phenyl phosphonate and another at the 
phenyl propyl phosphonate, but like C'la has a minimum sensitivity to phenyl 
ethyl  phosphonate.  Chymotrypsin demonstrates  a  single  peak in  sensitivity 
at the phenyl propyl phosphonate. 
In the alkyl phosphonate series, the optimum activity against C'la, trypsin, 
and  chymotrypsin  occurs respectively with  butyl phosphonate,  hexyl phos- 
phonate, and heptyl phosphonate. 
TABLE I 
Effect of a Terminal Amino Group on Inhibition of C'la 
5-Aminopentyl phosphonate  ................................ 
6-Aminohexyl phosphonate ................................ 
Pentyl phosphonate  ....................................... 
Hexyl phosphonate ...................................... 
ho 
1.5X 10  -5 
3.5X 10  "5 
1.4X 10  'a 
3.7X lO  -3 
With the w-chloroalkyl  phosphonates, chymotrypsin gives a  single peak at 
the  6-chlorohexyl  phosphonate,  whereas  both  C'la  and  trypsin  show peak 
activity at the 3-chloropropyl phosphonate. However, C'la has a sharp mini- 
mum  in  susceptibility  to  inhibition  with  the 5-chloropentyl  phosphonate, 
whereas with trypsin, a much more shallow,  but distinct minimum occurs at 
the 6-chlorohexyl  phosphonate. 
Table I  demonstrates that placing  an amino group on the terminal carbon 
of the pentyl and hexyl phosphonate increases  their inhibitory potency against 
C'la approximately lO0-fold. 
Inhibition  of whole complement: The inhibitory activity of the phenyl alkyl 
phosphonates against the hemolytic activity of commercial  fresh frozen com- 
plement is depicted in Fig. 3, A and B. Fig. 3, A demonstrates that a straight 
line relationship is obtained when the logarithm of the per cent activity remain- 
ing  is  plotted  against  the  concentration  of  p-nitrophenylethyl  phenylphos- 
phonate.  This result is expected from Equation  1, when the time,  t,  is held 
constant, and the inhibitor  concentration is varied. The time, t,  that  the in- 
hibitor has to act is presumably the interval between the activation of C'lp 
to C'la and the action of C'la on C'4 and C'2. This time, of course, is unknown, ELMER L.  BECKER AND K.  FRANK AUSTEN  497 
but from the results it is apparently constant. Thus, the concentration giving 
50 per cent inhibition of whole complement action can by symbolized by I~., 
the * signifying  that the time is not known. The value for I~0. is obtained di- 
rectly from the plot of the per cent activity remaining  versus concentration of 
the inhibitor. The negative logarithm of I~o. then becomes plso..  In Fig.  3, B, 
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plso.  is plotted against  the number of carbon atoms in the alkyl chain of the 
phenyl alkyl phosphonate series. It is evident that as with C'la (Fig. 2, A) the 
benzyl phosphonate gives maximum and  the phenyl ethyl phosphonate gives 
minimum inhibition. 
Fresh frozen guinea serum obtained from guinea pigs in our own laboratory 
or commercial  lyophilized  complement was used to test the inhibitory activity 
of the alkyl phosphonates. When the logarithm of the per cent activity remain- 
ing was plotted against the concentration of the propyl, butyl, or pentyl phos- 498  SPECIFICITY  OF  INHIBITION BY  PHOSPHONATE  ESTERS 
phonate, a straight line extrapolating to 100 per cent activity at zero concen- 
tration  was  not  obtained  with  the  fresh  frozen  serum.  However,  with  the 
commercial lyophilized complement a  straight  line  extrapolating to  100  per 
cent at zero concentration was observed and a peak in the inhibitory activity 
was obtained with the butyl phosphonate. 
Inhibition  of Antigen-Induced  Histamine Release.--The  inhibition given by 
varying concentrations of the phenyl, 3-chloropropyl, benzyl, and butyl phos- 
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Fzo. 4. The relationship between the logarithm of the per cent of histamine release remain- 
ing and the concentration of (A) phosphonate inhibitom, (B) diisopropyl  phosphofluoridate 
(data from reference 12) and (C) L-tryptophan ethyl ester and salicylaldoxime (data from 
references 12 and 21 respectively). Antigen-induced histamine release in buffer without in- 
hibitor was arbitrarily assigned a value of 100 per cent. 
phonates are seen in Fig. 4, A. All of the inhibitors gave a straight line when 
the logarithm of the per cent histamine release remaining was plotted against 
the inhibitor concentration. Replotting of the data (Fig. 4, B) for inhibition of 
histamine  release by diisopropyl phosphofluoridate reported previously (12) 
demonstrated  the  same  relationship,  even  to  97.5  per  cent  inhibition.  The 
previously reported data for inhibition of histamine release by salicylaldoxime 
(21) and L-tryptophan ethyl ester (12) failed to give a straight line extrapolating 
to 100 per cent at zero inhibitor concentration (Fig. 4, C). 
The concentration giving 50 per cent inhibition, 150, was  obtained for each 
phosphonate by plotting the logarithm of the per cent histamine release remain- 
ing against inhibitor concentration. From this the pI6o, was calculated. The *, O  t~ 
O  t~ 
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as with whole complement inhibition, signifies that the time interval over which 
the inhibitor is acting is unknown. 
In Fig. 5, the pattern of inhibition (#I~)  of antigen-induced histamine re- 
lease given by the phenyl alkyl, alkyl, and chloroalkyl phosphonates is coin- 
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pared to the inhibition of C'la given by these same compounds. In the phenyl 
alkyl series  (Fig.  5,  A)  benzyl  phosphonate  gives  peak  inhibition  of  both 
histamine release and C~la but there is no minimum in inhibition of histamine 
release with the phenylethyl phosphonate. In the alkyl series  (Fig. 5 B), butyl 
phosphonate shows peak activity against both histamine release and C'la. In 
the chloroalkyl series (Fig. 5, C) 4-chlorobutyl phosphonate is as active an in- 
hibitor of histamine release as the 3-chloro compound whereas the 3-chlorophos- 500  SPECIFICITY  OF  INHJ.I~ITION  BY  PHOSPHONATE  ESTERS 
phonate is distinctly more active as an inhibitor of Cqa. Moreover the 5-chloro- 
pentyl  phosphonate  is  a  stronger  inhibitor  of  histamine  release  than  the 
6-chlorohexyl phosphonate, although the reverse is true of the inhibition of C'la. 
The  inhibition  of  histamine  release  by  5-aminopentyl and 6-aminohexyl 
phosphonate was compared to that given by pentyl and hexyl phosphonate 
(Table II). The addition of an amino group to the terminal carbon on the pentyl 
and hexyl phosphonates considerably depresses the ability of the phosphonates 
to prevent histamine release; this contrasts markedly with the increased in- 
hibitory activity against Cqa produced by the same substitution (Table I). 
As is also seen in Table II, the presumed reversible inhibitor TAMe (tosyl 
L-arginine methyl ester)  gave no inhibition of histamine release  whether  it 
TABLE II 
Effect of Basic Terminal  Croup on the InhiMtion of Anaphylactic  Histamine Release 
5-Aminopentyl  phosphonate  .................. 
Pentyl phosphonate  ......................... 
6-Aminohexyl  phosphonate  ................... 
Hexyl phosphonate  .......................... 
TAMe:~  .................................... 
TAMe preincubated 5 minutes  ................ 
Concentration  Inhibition  I~e* 
X 10  4  X 10  4 
M 
5.0 
5.0 
5.0 
3.3 
100 
100 
#er  cestJ 
19 
47 
9.4 
26 
0 
0 
M 
16 
5.5 
44 
7.4 
~t Tosyl L-arginine methyl ester. 
was added to the tissues in the standard fashion, 10 seconds before adding the 
antigen, or allowed to preincubate with the tissue 5 minutes before addition. 
DISCUSSION 
It is evident that the pattern of inhibition of these phosphonate esters against 
C'la is as unique as that observed previously for acetyl-cholinesterase, chymo- 
trypsin, and trypsin (7,  14). The pattern of inhibition of acetylcholinesterase 
is completely different from that of chymotrypsin, trypsin, and C'la (Fig. 2). 
Chymotrypsin has only a  few points of likeness to the latter two enzymes. 
CPla and trypsin, however, although obviously different have an over-all simil- 
arity in the specificity of their reactions with the various phosphonates: in the 
phenyl alkyl series both enzymes give a minimum in activity with phenylethyl 
phosphonate; in the chloroalkyl series, 3-chloropropyl phosphonate gives maxi- 
mum inhibition of both enzymes and with the two enzymes an increase in chain 
length leads to compounds showing a distinct mimimum in activity; moreover, 
placing an amino group on the terminal carbon of the alkyl phosphonate clearly 
facilitates the reaction with both enzymes. C'la and trypsin might, therefore, ELMER  L. BECKER  AND  K. ;FRANK AUSTEN  501 
be  called  "parazymes"~;  i.e.,  enzymes  which  have  a  similar  although  not 
identical specificity. Here, the relation is defined in terms of the specificity of 
reaction with the hemisubstrates, not the complete  substrates. 
The pattern of reactivities  of the phosphonate esters  given by the various 
enzymes is a reflection of the structure of the enzyme, and more particularly of 
the active center of the enzyme. Thus, the inhibition by phosphonates can be 
used to draw inferences as to the nature of the active center in the same manner 
as have the reactions of enzymes with complete substrates. 
The presence  of an anionic  site in trypsin at a  definite  distance from the 
esteratic site is suggested by the fact that positively charged amino acids such 
as lysine and arginine are required  in the preferred substrates for trypsin. The 
minimum in inhibition of trypsin given by the  6-chloro-hexyl  phosphonate 
might be due to the repulsion of the electron-rich  chloro group by the putative 
anionic site (15). By the same reasoning, the minimum in the inhibition of C'I 
given  by the 5-chloropentyl  phosphonate could be due to the possession of a 
similar anionic group. The difference between trypsin and C'la, or at least one 
of the differences, might then be  in  the distances  between  the anionic  and 
esteratic sites in the two enzymes; the distance in Cqa possibly being less than 
in trypsin. The above  reasoning is in accord  with both the fact that Cqa is 
active against TAMe, and not against lysine ethyl ester. 
With certain organophosphorus  inhibitors  and certain enzymes it has  been 
demonstrated that the elements of structure which are of importance for the 
activity of a complete substrate with an enzyme are the same as the elements 
of structure which are of importance for the reaction of the hemi-substrate with 
the same enzyme (7, 22, 23). This can be expected to be true only if the acyla- 
tion reaction is the rate-limiting step in the reaction of the enzyme with the 
complete  substrate (7,  24)  because this is the reaction which  corresponds  to 
phosphorylation by the organophosphorus  inhibitor. 
Acylation is apparently the rate-limiting reaction of fatty acid esters  with 
trypsin (25), and the alkyl phosphonate giving optimum inhibition of trypsin 
corresponds in chain length to the fatty acid ester showing maximum substrate 
activity with the same enzyme (7). The marked increase of inhibitory activity 
of the aminoalkyl phosphonates  with both trypsin (26) and  C'la  (Table  I) 
compared  to the corresponding  alkyl phosphonates  suggests that acylation is 
rate-limiting in the reaction of these  enzymes with esters  of the basic amino 
acids. The addition of an amino group to the pentyl phosphonate increases its 
inhibitory activity against trypsin 4000-fold (26) but  only 100-fold against 
Cqa. This is in accord with the fact that lysine methyl ester is a good substrate 
for trypsin, but is not a substrate of Cqa, (9). This quantitative correspondence 
between the structural requirements  for a good substrate and a good inhibitor 
2  We wish to thank Dr. George Fostoropoulous  for suggesting the prefix for this term. 502  SPECIFICITY OF INHIBITION BY PHOSPHONATE  ESTERS 
can be taken as additional evidence that the acylation reaction is rate-limiting 
with these substrates. 
When the deacylation reaction is rate-limiting  there is no longer any neces- 
sary structural relationship between substrate and inhibitor.  Deacylation is the 
rate-limiting  step in the reaction of chymotrypsin with substrates containing 
aromatic  amlno acids  (4, 5).  This may explain  the finding  that  phenylethyl 
phosphonate, corresponding  in length of alkyl chain to phenylalanine is not the 
best of the phenyl alkyl phosphonate inhibitors of chymotrypsin (Fig. 2, A) (7). 
C11a is  capable  of hydrolyzing  substrates  containing  aromatic  amino  acids 
(9,  27),  nevertheless, the best phenyl alkyl phosphonate  inhibitor  of C'la is 
the benzyl and not phenylethyl phosphonate. This lack of correspondence  be- 
tween the structural requirements for inhibitory and substrate activity suggests 
that with C~la, the deacylation reaction is rate-limiting. 
The pattern of inhibition  of histamine release by the alkyl, phenyl alkyl, and 
chloroalkyl phosphonates  is similar  to the inhibition  of C'la by these same 
compounds (Fig.  5 A, B, and C). This is additional evidence for the previous 
suggestion  (12) that the activation of an organophosphorus-inhibitable esterase 
is necessary for the antigen-induced histamine release of guinea pig lung.  The 
linear  dose-response  curve of inhibition  of histamine  release  by organophos- 
phorus inhibitors  (Fig.  4, A and B) is further support for such an hypothesis. 
This is underlined by the difference in dose-response  curve given by L-trypto- 
phan ethyl ester and salicylaldoxime  which are presumably reversible competi- 
tive inhibitors.  An additional implication of the straight line relationship be- 
tween  the  logarithm  of  the  per  cent  histamine  release  remaining  and  the 
concentration of organophosphorus inhibitor is that  the amount of histamine 
released  is directly proportional to the concentration of activated esterase. 
Although there is a great similarity in the patterns of inhibition  of C~la and 
of histamine release given by the phosphonate esters there are also distinct and 
definite differences. In contrast to C'la, there is no minimum in the inhibition 
of histamine release by the phenyl ethyl phosphonate; there is no well defined 
peak in inhibition  of histamine release by the 3-chloropropyl  phosphonate; no 
minimum in inhibition by the 5-chloropentyl phosphonate; and the aminoalkyl 
phosphonates are distinctly less active inhibitors of histamine release than the 
corresponding  alkyl phosphonates (Table II). 
In determining whether these differences signify  that different enzymes are 
operating in the two systems there are several factors to be considered.  The 
inhibition of C'la, involves the inactivation of a single enzyme already existing 
in the activated state, whereas in the inhibition  of histamine  release,  we are 
forced to assume that it is the inactivation of only one enzymatic step which is 
being studied. Moreover, in this latter system the esterase exists in an inactive 
form, and only after activation is it susceptible to inhibition by the phosphonate 
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centage histamine  release  remaining and  the concentration of inhibitor  (Fig. 
5, A and B) not only indicates that the necessity for activation does not cause 
any disturbance in the reaction of organo-phosphorus inhibitor with enzyme, 
but also that a single step is being inhibited. This suggestion is further strength- 
ened by the finding with whole complement where there is also a requirement 
for the activation of an organophosphorus-inhibitable esterase.  In this instance, 
the linear  relationship  in  the inhibition  of whole  complement  by the phos- 
phonates is obtained (Fig. 3, A), and there is a parallelism  between the pattern 
of inhibition given by the phenyl alkyl phosphonates acting on CPla and on 
whole complement (Fig. 3, B). 
The phosphonates inhibit CPla on the surface of the red cell, and there is no 
question of there being differences in the access of the various inhibitors to the 
enzyme. In the case of the inhibition of histamine release from sliced guinea pig 
lung this question can not be so easily dismissed.  The target cell, presumably 
the mast cell, is imbedded in the tissue and there very well may be barriers 
limiting access of the inhibitor to the target cell either on the basis of the size 
of the inhibitor, lipid solubility, or charge. 
These presumed barriers do not prevent egg albumin,  the antigen,  with a 
molecular weight over 100 times that of the inhibitor from initiating histamine 
release within 15 seconds of its addition to the finely chopped sensitized  tissue 
(12).  On the other hand,  the inhibitors are distinctly more lipid-soluble  than 
egg albumin raising  the possibility that  the pattern  of inhibition reflects  the 
lipid solubility of the inhibitors. This is not likely, since in no case is the maxi- 
mum of inhibition given by either the most water-soluble or most lipid-soluble 
compound of any of the homologous series  studied.  The  poor inhibition  of 
histamine  release  exhibited  by the  aminoalkyl  phosphonates,  or  by TAMe 
(Table II) could be due to the binding of the positively charged inhibitors by 
some element of the tissue.  There is no present evidence for or against  this 
possibility. Our tentative conclusion,  however, is that the organophosphorus- 
inhibitable  enzymes in the two guinea pig systems, serum complement, and 
antigen-induced histamine release from lung are similar  but different; i.e. they 
are parazymes. 
This conclusion  immediately raises  the question of whether the enzyme in 
quinea pig lung is in fact "chymotrypsin-like" as has been suggested (12). In 
the phenyl alkyl series, there is a difference of two carbon atoms between the 
benzyl phosphonate  giving peak inhibition  of histamine  release,  and  phenyl 
propyl phosphonate giving  peak inhibition with chymotrypsin. Similarly,  the 
peak is shifted by 3 carbon atoms in the alkyl series and between 2 and 3 carbon 
atoms in the chloroalkyl series. However, the aminoalkyl compounds are not 
only less active as inhibitors of histamine release,  but as inhibitors of chymo- 
trypsin as well (26). The differences in the patterns of inhibition of histamine 
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than the similarities.  From this latter point of view, the guinea pig lung enzyme 
can not be considered chymotrypsin-like. However, if chymotrypsin-like implies 
the capability of splitting characteristic chymotrypsin substrates such as aro- 
matic amino acid esters, the answer must be more equivocal. It has already been 
pointed out that no necessary connection between the structure  of complete 
substrates  and hemisubstrate need exist  unless  the acylation of the enzyme 
by the complete substrate is  rate-limiting.  This  certainly is not true  of the 
reaction  of chymotrypsin,  nor probably of C'la with aromatic  amino  acid- 
containing substrates and very well might not be true of the guinea pig lung 
enzyme. Therefore,  the dissimilarity in the patterns  of reactivity of chymo- 
trypsin and guinea pig lung enzyme with phenyl alkyl phosphonates can not 
be used as an argument that the guinea pig lung enzyme is incapable of reacting 
with aromatic amino acid-containing substrates. 
The suggestion  that  the guinea pig lung enzyme is chymotrypsin-like was 
based on wholly indirect  reasoning  relating  the  presence  of an  organophos- 
phorus-inhibitable step to the ability of histamine  release  to be depressed by 
aromatic amino acid-containing derivatives. Here, the ability of the enzyme to 
bind these aromatic amino acid derivatives and the ability of the enzyme to be 
phosphorylated by the corresponding  phenyl alkyl phosphonates involving as 
they both do the initial part of the reaction of the enzyme would be expected 
to be more comparable. On this basis, the difference in inhibitory pattern of the 
phenyl alkyl phosphonates for histamine release and chymotrypsin is probably 
significant.  It therefore seems  probable that  the aromatic amino acid deriva- 
tives would not be particularly good inhibitors of the guinea pig lung esterase 
and thus, the inhibition observed is due to their acting at another step in the 
sequence. 
This last conclusion  is in accord with the recent finding  that  the primary 
site of inhibition of complement by aromatic amino acid derivatives is not on 
the C'I, organophosphorus-inhibitable step, but on one of the later C'3 steps 
(28). If the conclusion in regard to the site of inhibition of histamine release by 
aromatic  amino  acid  derivatives  is  correct  this  would  be  another  general 
similarity  with  the  complement  system.  It  is  felt  that  the  differences  and 
similarities  between the histamine  release  reaction and complement reaction 
which have been detailed here and elsewhere (12) can best be reconciled by the 
hypothesis that  they are two parazymous systems; i.e.,  systems made up of 
components which are similar  but not identical in their reactivity. 
SUMMARY 
The ability of a number p-nitrophenylethyl alkyl, phenyl alkyl, chloroalkyl, 
and aminoalkyl phosphonates to inhibit  the activated first component (C'la) 
of guinea pig complement, and the antigen-induced release  of histamine from 
sliced, perfused guinea pig lung has been compared. C'la in its reactivity with ELMER L.  BECKER AND  K.  I~RANK AUSTEN  505 
these phosphonates is  distinctly more similar  to  trypsin than  to any of the 
other enzymes studied previously. It is suggested that both trypsin and C'la 
possess an anionic group in the active center of the respective enzyme, but the 
distance between the anionic and esteratic site in Cqa might be less than in 
trypsin. 
The pattern of inhibition of histamine relase by the alkyl, phenyl alkyl, and 
chloroalkyl phosphonates  is  similar to the inhibition of  C'la  by these com- 
pounds, although distinct differences are apparent. The aminoalkyl phospho- 
nates are distinctly less active inhibitors of histamine release than the corre- 
sponding alkyl phosphonates, whereas the reverse is true of the inhibition of 
C'la.  On  the  basis  of these differences, it is  tentatively concluded that  the 
organophosphorus-inhibitable enzymes in the guinea pig systems studied here 
are similar but not identical. 
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